Huntington National Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Sell |
136,185
-10,553
| -7% | -$870K | 0.06% | 208 |
|
|
2025
Q4 | $12.5M | Sell |
146,738
-4,645
| -3% | -$381K | 0.08% | 173 |
|
|
2025
Q3 | $11.8M | Sell |
151,383
-14,023
| -8% | -$1.1M | 0.07% | 181 |
|
|
2025
Q2 | $12.9M | Sell |
165,406
-8,527
| -5% | -$636K | 0.08% | 166 |
|
|
2025
Q1 | $12.6M | Sell |
173,933
-20,995
| -11% | -$1.5M | 0.09% | 167 |
|
|
2024
Q4 | $14.4M | Sell |
194,928
-26,219
| -12% | -$1.84M | 0.1% | 151 |
|
|
2024
Q3 | $14.6M | Sell |
221,147
-20,919
| -9% | -$1.52M | 0.11% | 159 |
|
|
2024
Q2 | $22.4M | Sell |
242,066
-11,507
| -5% | -$1.02M | 0.17% | 119 |
|
|
2024
Q1 | $24.2M | Sell |
253,573
-23,798
| -9% | -$2M | 0.2% | 118 |
|
|
2023
Q4 | $21.1M | Sell |
277,371
-28,730
| -9% | -$2M | 0.19% | 121 |
|
|
2023
Q3 | $21.2M | Sell |
306,101
-19,135
| -6% | -$1.54M | 0.21% | 115 |
|
|
2023
Q2 | $30.7M | Sell |
325,236
-16,679
| -5% | -$1.45M | 0.28% | 99 |
|
|
2023
Q1 | $28.3M | Sell |
341,915
-56,038
| -14% | -$4.4M | 0.28% | 99 |
|
|
2022
Q4 | $29.7M | Sell |
397,953
-242,035
| -38% | -$18.7M | 0.31% | 92 |
|
|
2022
Q3 | $52.9M | Sell |
639,988
-126,017
| -16% | -$12.1M | 0.6% | 44 |
|
|
2022
Q2 | $72.8M | Sell |
766,005
-52,307
| -6% | -$5.42M | 0.78% | 33 |
|
|
2022
Q1 | $96.3M | Buy |
818,312
+11,148
| +1% | +$1.25M | 0.89% | 29 |
|
|
2021
Q4 | $105M | Buy |
807,164
+23,742
| +3% | +$2.77M | 0.95% | 26 |
|
|
2021
Q3 | $88.7M | Buy |
783,422
+10,997
| +1% | +$1.26M | 0.89% | 25 |
|
|
2021
Q2 | $80M | Buy |
772,425
+1,653
| +0.2% | +$156K | 0.8% | 34 |
|
|
2021
Q1 | $64.5M | Buy |
770,772
+11,409
| +2% | +$965K | 0.78% | 40 |
|
|
2020
Q4 | $69.3M | Sell |
759,363
-42,009
| -5% | -$3.48M | 0.91% | 31 |
|
|
2020
Q3 | $64M | Sell |
801,372
-2,118
| -0.3% | -$165K | 0.93% | 29 |
|
|
2020
Q2 | $55.5M | Sell |
803,490
-67,428
| -8% | -$4.79M | 0.88% | 32 |
|
|
2020
Q1 | $54.8M | Sell |
870,918
-60,762
| -7% | -$4.38M | 1.03% | 23 |
|
|
2019
Q4 | $72.5M | Buy |
931,680
+18,360
| +2% | +$1.43M | 1.09% | 19 |
|
|
2019
Q3 | $67M | Sell |
913,320
-14,334
| -2% | -$1.01M | 1.08% | 20 |
|
|
2019
Q2 | $57.1M | Buy |
927,654
+50,184
| +6% | +$3.03M | 0.92% | 26 |
|
|
2019
Q1 | $56M | Buy |
877,470
+22,365
| +3% | +$1.28M | 0.92% | 23 |
|
|
2018
Q4 | $43.7M | Buy |
855,105
+84,945
| +11% | +$4.3M | 0.78% | 35 |
|
|
2018
Q3 | $44.7M | Buy |
770,160
+128,979
| +20% | +$6.31M | 0.7% | 40 |
|
|
2018
Q2 | $31.1M | Buy |
641,181
+75,081
| +13% | +$3.5M | 0.52% | 61 |
|
|
2018
Q1 | $26.3M | Buy |
566,100
+116,580
| +26% | +$5.06M | 0.44% | 67 |
|
|
2017
Q4 | $16.9M | Buy |
449,520
+434,166
| +2,828% | +$15.9M | 0.27% | 115 |
|
|
2017
Q3 | $559K | Buy |
15,354
+750
| +5% | +$28.6K | 0.01% | 417 |
|
|
2017
Q2 | $576K | Buy |
14,604
+624
| +4% | +$22.8K | 0.01% | 415 |
|
|
2017
Q1 | $438K | Sell |
13,980
-24
| -0.2% | -$751 | 0.01% | 466 |
|
|
2016
Q4 | $438K | Hold |
14,004
| – | – | 0.01% | 474 |
|
|
2016
Q3 | $563K | Sell |
14,004
-1,041
| -7% | -$39.2K | 0.01% | 420 |
|
|
2016
Q2 | $500K | Buy |
15,045
+5,457
| +57% | +$187K | 0.01% | 381 |
|
|
2016
Q1 | $455K | Sell |
9,588
-8,172
| -46% | -$225K | 0.01% | 442 |
|
|
2015
Q4 | $467K | Sell |
17,760
-816
| -4% | -$21.2K | 0.01% | 418 |
|
|
2015
Q3 | $440K | Buy |
18,576
+342
| +2% | +$8.26K | 0.01% | 449 |
|
|
2015
Q2 | $433K | Sell |
18,234
-942
| -5% | -$21.3K | 0.01% | 462 |
|
|
2015
Q1 | $455K | Buy |
19,176
+1,194
| +7% | +$26.8K | 0.01% | 445 |
|
|
2014
Q4 | $381K | Sell |
17,982
-194,232
| -92% | -$3.9M | 0.01% | 483 |
|
|
2014
Q3 | $3.61M | Sell |
212,214
-185,868
| -47% | -$2.93M | 0.07% | 272 |
|
|
2014
Q2 | $5.7M | Sell |
398,082
-74,598
| -16% | -$1.01M | 0.11% | 200 |
|
|
2014
Q1 | $5.84M | Buy |
472,680
+426,336
| +920% | +$4.92M | 0.11% | 222 |
|
|
2013
Q4 | $508K | Buy |
46,344
+870
| +2% | +$9.81K | 0.01% | 451 |
|
|
2013
Q3 | $528K | Sell |
45,474
-8,580
| -16% | -$100K | 0.02% | 421 |
|
|
2013
Q2 | $605K | Buy |
+54,054
| New | +$640K | 0.02% | 389 |
|
Other funds holding EW
VCM
VPM
Huntington National Bank's EW Position: Q1 2026 in Review
Huntington National Bank reduced its Edwards Lifesciences (EW) stake by 7.2% in Q1 2026, selling an estimated $870K and leaving 136,185 shares worth $10.9M. The position accounts for 0.06% of the portfolio, ranked #208.
Huntington National Bank first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $105M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Huntington National Bank held 136,185 shares of Edwards Lifesciences worth $10.9M as of Q1 2026.
- Huntington National Bank sold 10,553 Edwards Lifesciences shares in Q1 2026, an estimated $870K.
- Edwards Lifesciences made up 0.06% of Huntington National Bank's portfolio in Q1 2026, its #208 holding.
- Huntington National Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Huntington National Bank's Edwards Lifesciences position peaked at $105M in Q4 2021.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.